Adil I Daud Selected Research

Fatigue

3/2015	Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors.
2/2012	Phase I study of bosutinib, a src/abl tyrosine kinase inhibitor, administered to patients with advanced solid tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adil I Daud Research Topics

Disease

45	Melanoma (Melanoma, Malignant) 03/2024 - 01/2006
40	Neoplasms (Cancer) 02/2024 - 12/2005
7	Neoplasm Metastasis (Metastasis) 03/2024 - 12/2008
3	Skin Neoplasms (Skin Cancer) 01/2022 - 12/2019
3	Breast Neoplasms (Breast Cancer) 12/2005 - 05/2004
2	Inflammation (Inflammations) 12/2023 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2008
2	Merkel Cell Carcinoma 01/2020 - 01/2018
2	Disease Progression 01/2018 - 11/2014
2	Thrombocytopenia (Thrombopenia) 03/2015 - 12/2011
2	Fatigue 03/2015 - 02/2012
2	Nausea 03/2015 - 02/2012
2	Necrosis 12/2008 - 11/2008
1	Rhinosinusitis 12/2023
1	Uveal melanoma 11/2016
1	Constipation 03/2015
1	Neutropenia 03/2015
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2014
1	Pigmented Nevus (Melanocytic Nevus) 11/2014
1	Sarcoma (Soft Tissue Sarcoma) 03/2013
1	Diarrhea 02/2012
1	Anorexia 02/2012
1	Vomiting 02/2012
1	Exanthema (Rash) 02/2012
1	Myocardial Infarction 12/2011

Drug/Important Bio-Agent (IBA)

8	pembrolizumabIBA 12/2023 - 01/2016
7	Immune Checkpoint InhibitorsIBA 02/2024 - 10/2015
7	Interleukin-12 (IL 12)IBA 09/2022 - 12/2008
6	Proteins (Proteins, Gene)FDA Link 02/2024 - 12/2005
5	CytokinesIBA 03/2024 - 01/2018
5	IpilimumabIBA 01/2023 - 10/2015
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2023 - 03/2013
4	Biomarkers (Surrogate Marker)IBA 11/2020 - 01/2016
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2006
4	LigandsIBA 01/2017 - 01/2014
3	AntibodiesIBA 11/2016 - 01/2014
3	Valproic Acid (Depakote)FDA LinkGeneric 11/2011 - 12/2005
2	Mitogen-Activated Protein KinasesIBA 02/2024 - 03/2013
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2023 - 07/2017
2	VaccinesIBA 01/2022 - 01/2006
2	Programmed Cell Death 1 ReceptorIBA 01/2022 - 04/2015
2	RNA (Ribonucleic Acid)IBA 01/2021 - 12/2018
2	AntigensIBA 01/2020 - 01/2019
2	CTLA-4 AntigenIBA 01/2017 - 01/2016
2	NivolumabIBA 01/2016 - 10/2015
2	bosutinibIBA 02/2012 - 06/2009
2	Peptides (Polypeptides)IBA 12/2011 - 01/2006
2	Interleukin-2 (IL2)IBA 12/2011 - 08/2010
2	Histone Deacetylase InhibitorsIBA 11/2011 - 04/2009
2	cositecanIBA 11/2011 - 04/2009
2	Topoisomerase I InhibitorsIBA 11/2011 - 04/2009
2	Histones (Histone)IBA 12/2005 - 05/2005
2	Topoisomerase II InhibitorsIBA 12/2005 - 12/2005
1	talimogene laherparepvecIBA 03/2024
1	Messenger RNA (mRNA)IBA 03/2024
1	Triamcinolone (Aristocort)FDA Link 12/2023
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 12/2023
1	tovorafenibIBA 01/2023
1	NexusIBA 01/2022
1	trametinibIBA 10/2020
1	dabrafenibIBA 10/2020
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2020
1	C-Type Lectins (C-Type Lectin)IBA 01/2020
1	Transcription Factors (Transcription Factor)IBA 12/2018
1	HLA-DR Antigens (HLA-DR)IBA 11/2018
1	B7-H1 AntigenIBA 12/2016
1	Death Domain ReceptorsIBA 11/2016
1	Gemcitabine FDA Link 03/2015
1	MK-8776IBA 03/2015
1	Checkpoint Kinase 1IBA 03/2015
1	cobimetinibIBA 11/2014
1	VemurafenibIBA 11/2014
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 03/2013
1	TOR Serine-Threonine KinasesIBA 03/2013
1	Growth Factor ReceptorsIBA 03/2013
1	Phosphotransferases (Kinase)IBA 02/2012
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	Tyrosine Kinase InhibitorsIBA 02/2012
1	Tumor Suppressor Protein p53IBA 12/2011
1	ALT-801IBA 12/2011
1	EpitopesIBA 12/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 12/2011
1	HLA-A*02:01 antigenIBA 12/2011
1	CamptothecinIBA 11/2011
1	Bevacizumab (Avastin)FDA Link 01/2011
1	Sunitinib (Sutent)FDA Link 01/2011
1	Platinum Compounds (Compounds, Platinum)IBA 06/2009
1	Dasatinib (BMS 354825)FDA Link 06/2009
1	Cisplatin (Platino)FDA LinkGeneric 06/2009
1	Temozolomide (Temodar)FDA LinkGeneric 06/2009
1	PhosphotyrosineIBA 06/2009
1	Paclitaxel (Taxol)FDA LinkGeneric 06/2009
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2009

Therapy/Procedure

29	Therapeutics 03/2024 - 07/2007
22	Immunotherapy 03/2024 - 01/2006
6	Drug Therapy (Chemotherapy) 01/2017 - 07/2006
2	Injections 03/2024 - 01/2020
1	Metastasectomy 03/2024
1	Radiotherapy 01/2018
1	Electrodes (Electrode) 12/2008